Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: Favorable impact of chronic graft-versus- host disease on survival and relapse

Haematologica

Volumn 83, Issue 10, 1998, Pages 896-903

  Zikos, Panagiotis ^a   Van Lint, Maria Teresa ^a   Lamparelli, Tommaso ^a   Gualandi, Francesca ^a   Occhini, Domenico ^a   Bregante, Stefania ^a   Berisso, Gianni ^a   Mordini, Nicola ^a   Incagliato, Massimo ^a   Fugazza, Giusy ^b   Sessarego, Mario ^b   Bacigalupo, Andrea ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute lymphoblastic leukemia; Graft versus host disease; Graft versus leukemia; Hemopoietic stem cell transplant

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; THIOTEPA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CHRONIC DISEASE; CYTOGENETICS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PROGNOSIS;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; RECURRENCE; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 18744433056     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Acute lympboblastic leukemia in adults [editorial]. Lancet 1986; 1:952-3.
2. Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71:123-31.
3. Uderzo C, Valsecchi MG, Bacigalupo A, et al. Treatment of childhood acute lymphoblastic leukaemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten years experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. J Clin Oncol 1995; 13:352-8.
4. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukaemia in adults. Blood 1995; 85:1151-68.
5. Horowitz M, Messerer D, Hoeizer D, et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukaemia in first remission. Ann Intern Med 1991; 115:13-8.
6. Zhang MJ, Hoeizer D, Horowitz MM, et al. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. Ann Intern Med 1995; 123:428-31.
7. Sebban C, Lepage E, Vernant JP, et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukaemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukaemia. J Clin Oncol 1994; 12:2580-7.
8. Chao NJ, Forman SJ, Schmidt GM, et al. Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukaemia during first complete remission. Blood 1991; 78:1923-7.
9. Wingard JR, Piantadosi S, Santos GW, et al. Allogeneic bone marrow transplantation for patients with high-risk acute iymphoblastic leukemia. J Clin Oncol 1990; 8:820-30.
10. Kantarjian HM, Walters RS, Keating MJ, et al. Results of the vincristine, doxorubicin and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukaemia. J Clin Oncol 1990; 8:994-1004.
11. Bassan R, Lerede T, Barbui T. Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Haematologica 1996; 81:20-36
12. Barrett AJ, Horowitz MM, Gale RP, et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74:862-71.
13. Fiere D, Lepage E, Sebban C, et al. Adult acute lymphoblastic leukaemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. J Clin Oncol 1993; 11:1990-2001.
14. Frassoni F, Labopin M, Gluckman E, et al. Results of allogeneic bone marrow transplantation for acute leukaemia have improved over time in Europe. Bone Marrow Transplant 1996; 17:13-8.
15. Gale RP, Horowitz MM, Ash RC, et al. Identical twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120:646.
16. Horowitz M, Gale RP, Sondel PM, et al. Graft versus leukaemia reactions after bone marrow transplantation Blood 1990; 75:555.
17. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukaemia. Blood 1991; 78:2120.
18. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. New Engl J Med 1975; 63:832-8.
19. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host-disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18:295-304.
20. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
21. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34:187-202.
22. Doney K., Fisher LD, Appelbaum FR, et al. Treatment of acute lymphoblastic leukaemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft versus host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991; 7:453-9.
23. Roberts WM, Rivera GK, Raimondi SC, et al. Intensive chemotherapy for Philadelphia-positive acute lymphoblastic leukaemia. Lancet 1994; 343:331.
24. Forman SJ, O'Donnell MR, Nademanee AP, et al. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. Blood 1987; 70:587.
25. Barrett AJ, Horowitz M, Ash RC, et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukaemia. Blood 1992; 70:3067.
26. Bortin MM, Barrett AJ, Horowitz MM, Gale RP, Sobocinski KA, Rimm AA. Progress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980s: a report from the IBMTR. The International Bone Marrow Transplant Registry. Leukemia 1992; 6 (Suppl 2):196-7.
27. Deconinck E, Cahn Y-H, Milpied N, et al. Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia in first remission: long term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C, and melphalan). Bone Marrow Transplant 1998; 21:731-5.
28. Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 1993; 329:1296-301.
29. Ringden O, Hermans J, Labopin M, Apperley J, Gorin NC, Gratwohl A. The highest leukaemia free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft versus host disease. Leuk Lymphoma 1996; 24:71-9.
30. Copelan EA, Penza SL, Elder PJ, et al. Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemia. Bone Marrow Transplant 1996; 18:907-11.
31. Elfenbein GJ, Graham-Pole J, Weiner RS, et al. No prophylaxis for acute graft versus host disease. Progress in Bone Marrow Transplantation: Proceedings of the Fourth International UCLA Symposium on Bone Marrow Transplantation. Keystone, CO, 13-18 April, 1986, Alan R Liss: New York, 1987. p. 295-306.
32. Sullivan KM, Dig HJ, Sanders J, et al. Hyperacute graft-versus host disease in patients not given immunopression after allogeneic marrow transplantation. Blood 1986; 67:1172-5.
33. Bacigalupo A, Van Lint MT, Occhini D, et al. Increased risk of leukaemia relapse with high-dose cyclosporin A after allogeneic marrow transplantation for acute leukaemia. Blood 1991; 77:1423-8.
34. Kolb HJ, de Witte T, Mittermuller J, et al. for EBMT Chronic Leukaemia Working Party. Graft versus leukaemia donor buffy coat transfusions on recurrent leukaemia after marrow transplantation [abstract]. Blood 1993; 82:214a.
35. Barrett AJ, Malkovska V. Graft-versus-Leukemia: understanding and using the alloimmune response to treat haematological malignancies. Br J Haematol 1996; 93:754-61.
36. Bacigalupo A, Soracco M, Vassallo F, et al. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukaemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 927-32.
37. Mehta J, Powles R, Singhal S, Tait D, Swansbury J, Treleaven J. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16:133-7.
38. van Rhee F, Kolb H-J. Donor leukocytes transfusions for leukemic relapse. Curr opin Hematol 1995; 2: 423-30.